-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Yuxuan Liu, PhD1, Haowen Jiang, PhD2*, Lucille Stuani, PhD3,4*, Jolanda Sarno, PhD5, Pablo Domizi, PhD1, Milton Merchant1*, Dorra Jedoui4*, Astraea Jager1*, Min Huang, MD, PhD4*, Norman J. Lacayo, MD4*, Kathleen M. Sakamoto, MD, PhD6, Jiangbin Ye, PhD2* and Kara L. Davis, DO4

1Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Stanford, CA
2Department of Radiation Oncology, Stanford University School of Medicine, Stanford
3Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Montpellier, France
4Bass Center for Childhood Cancer and Blood Disorders, Department of Pediatrics, Stanford University, Stanford, CA
5Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, CA
6Department of Pediatrics, Stanford University, Stanford, CA

Cristina Borin1*, Tim Pieters, PhD2,3,4*, Pieter Van Vlierberghe, PhD2,3,4* and Panagiotis Ntziachristos, PhD1,5

1Ghent University, Ghent, Belgium
2Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium
3Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
4Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium
5Ghent University, Corneel Heymanslaan 10, Ghent, Belgium

Jae-Ho Yoon, MD1, Daehun Kwag2*, Gi June Min, MD1, Sung-Soo Park3*, Silvia Park4*, Sung-Eun Lee, MD5*, Byung-Sik Cho1*, Ki-Seong Eom1*, Yoo-Jin Kim1, Hee-Je Kim1, Chang-Ki Min1*, Seok-Goo Cho1*, Jong-Wook Lee, MD6 and Seok Lee1

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, Th, Seoul, South Korea
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
4Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
5Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
6Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea

Yan Huang1*, Luting Luo1,2*, Yanxin Chen1*, Zhengjun Wu1*, Jiazheng Li1,2*, Yangqi Xu1*, Lingyan Wang1*, Haojie Zhu3*, Ting Yang, MD, PhD4* and Jianda Hu, PhD1,2

1Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
3Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
4Department of Hematology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China

Giacomo Gotti, MD1*, Daniela Silvestri2*, Grazia Fazio, PhD2*, Chiara Palmi, PhD2*, Valentino Conter, MD2*, Maria Grazia Valsecchi, PhD3,4*, Carmelo Rizzari, MD1,3*, Barbara Buldini, MD, PhD5, Franco Locatelli, MD, PhD6, Andrea Biondi, MD1,3 and Giovanni Cazzaniga, PhD2,3

1Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
3School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
4Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
5Department of Pediatric Hematology and Oncology, University of Padova, Padua, Italy
6Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy

Signe Modvig, MD, PhD1,2*, Hanna Thorsson, PhD3*, Bodil Als-Nielsen, MD4*, Claus Christensen, PhD2*, Nina Friesgaard Øbro, PhD2*, Hans O. Madsen, Msc5*, Henrik Lilljebjörn, PhD6*, Kjeld Schmiegelow, MD, DMsc7,8*, Thoas Fioretos, MD, PhD9 and Hanne Vibeke Marquart, MD, PhD1,2*

1Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark
2Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
3Division of Clinical Genetics, Lund University, Lund, Sweden
4Department of Pediatrcis and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, DNK
5Department of Clinical Immunology, University Hospital Rigshospitalet, Copenhagen, Denmark
6Division of Clinical Genetics, Lund University, Lund, SWE
7Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, Copenhagen, Denmark
8Medical Faculty, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
9Department of Clinical Genetics, Lund University, Lund, Sweden

Sabina Enlund, MSc1*, Christina Neofytou1*, Indranil Sinha, PhD1*, Amanda Ramilo Amor1*, Anna B Nilsson, MD, PhD1*, Qingfei Jiang, PhD2, Ola Hermanson, PhD1* and Frida Holm, PhD1*

1Karolinska Institutet, Solna, Sweden
2UCSD, La Jolla, CA

Cesca Van De Ven, PhD1*, Mandy W.E. Smeets, MSc1,2*, Elisabeth M.P. Steeghs, PhD2* and Monique L. den Boer, PhD1,2

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children’s Hospital, Rotterdam, Netherlands

Tong Wang, MD1,2*, Jingbo Ni3*, Xue Chen, MD1*, Panxiang Cao, MS1*, Jinan Tan3*, Hongwei Zhang3*, Jiangcheng Fang1*, Xinying Wei3*, Jiaqi Chen, PhD3,4,5*, Xiaoli Ma, MD1*, Yang Zhang, MD6*, Fang Wang, MD7*, Yan Zhang3*, Yan Dai3* and Hongxing Liu2,3

1Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Lu Daopei Institute of Hematology, Beijing, China
3Hebei Yanda Lu Daopei Hospital, Langfang, China
4Department of Laboratory Medicine, Hebei Yanda Lu DaoPei Hospital, Langfang, China
5Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China
6Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China
7Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China

Nicolas Boissel, MD, PhD1*, Francoise Huguet, MD2*, Thibaut Leguay3*, Mathilde Hunault, MD, PhD4*, Rathana KIM, Pharm.D.5*, Yosr Hicheri6*, Marie Passet, Pharm.D. / Ph.D.7*, Patrice Chevallier, MD8, Marie Balsat, MD9*, Sebastien Maury10*, Anne Thiebaut, MD11*, Florence Van Obbergh12*, Thomas Cluzeau, MD, PhD13, Martine Escoffre Barbe, MD14*, Nicole Straetmans15, Johanna Konopacki16*, Amine Belhabri, MD17*, Alban Villate, MD18*, Florence Pasquier, MD, PhD19*, Didier Bouscary20*, Thorsten Braun, MD, PhD21, Sabine Blum22*, Victoria Cacheux23*, Caroline Bonmati, MD24*, Sebastian Wittnebel25*, Véronique Lhéritier26*, Norbert Ifrah, MD, PhD4, Carlos Graux27*, Yves Chalandon, MD28, Emmanuelle Clappier, PhD, PharmD29* and Herve Dombret, MD30

1Hôpital Saint-Louis, Paris, France
2IUCT-Oncopole, Toulouse, France
3Hopital Du Haut-Leveque, Pessac, FRA
4Hematology Department, CHU Angers, Angers, France
5Assistance Publique Des Hopitaux De Paris (AP-HP) - Universite Paris Descartes -, Paris, Ile-de-France, FRA
6Department of Hematology, Institut Paoli-Calmettes, Marseille, France
7APHP, Paris, FRA
8CHU de Nantes - Hôtel Dieu, Nantes, France
9Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
10Hematology Department, Hôpitaux universitaires Henri Mondor AP-HP & Université Paris Est Créteil, Créteil, France
11service d'hématologie clinique, CHUGA Grenoble, Grenoble, France
12Centre Hospitalier de Jolimont, La Louviere, BEL
13CHU Nice, Nice, FRA
14Department of hematology, Rennes, France
15Cliniques St-Luc, Université Catholique de Louvain, Bruxelles, BEL
16HIA PERCY, CLAMART, FRA
17Centre Leon Berard, Lyon, FRA
18CHRU Bretonneau, Tours, FRA
19INSERM U790, PR1, IGR, Villejuif, FRA
20APHP Cochin Hospital, Paris, FRA
21Clinical Hematology, Avicenne University Hospital, Assistance Publique – Hôpitaux de Paris, Bobigny, France
22Lausanne University Hospital CHUV, Lausanne, CHE
23CHU Estaing, Clermont Ferrand, FRA
24Hematology Department, CHU Nancy, Nancy, France
25Jules Bordet Institute, Université Libre de Bruxelles, Anderlecht, BEL
26Service d’Hématologie Coordination GRAALL, HCL, Hôpital Lyon Sud, Pierre Bénite, France
27Department of Hematology, Université catholique de Louvain, CHU UCL Namur - site Godinne, Yvoir, BEL
28Univ. Hospital of Geneva, Geneva, CHE
29Hôpital Saint-Louis, APHP, Paris, FRA
30HôPital Saint-Louis, Assistance Publique - HôPitaux De Paris (AP-H, Paris, FRA

Fabio D. Steffen, PhD1*, Andrej Lissat, MD2*, Julia Alten3*, Cornelia Eckert, PhD2*, Nicole Bodmer, MD1*, Bodil E. Thorhauge Als-Nielsen, MD4*, Adriana Balduzzi, MD5,6*, Barbara Buldini, MD, PhD7, Sarah Elitzur, MD8, Andras Kriston9*, Gergely Nyiri9*, Imre Västrik10*, Ferenc Kovacs9*, Francesco Ceppi, MD11, Lucie Sramkova, MD, PhD12*, Larissa Schori, Msc1*, Arianna Arpagaus, Msc1*, Silvia Gutnik, PhD1*, Andishe Attarbaschi, Prof., MD13*, Birgitte Klug Albertsen, MD14*, Jeanette Greiner, MD15*, Marc Ansari, MD, PhD16, Judith M. Boer, PhD17, Elad Jacoby, MD18, Martin Stanulla, MD19*, Uri Ilan, MD17*, Peter M. Hoogerbrugge, MD, PhD17, Tim Lammens, PhD, MSc20*, Barbara De Moerloose, MD21*, Petter Svenberg, MD22*, Nicolas von der Weid, MD23, David O'Connor, MD24*, Hélène Cavé, PhD25*, Franco Locatelli, MD, PhD26, Martin Schrappe, MD27, André Baruchel, MD, PhD25, Andreas Kulozik, MD, PhD28, Kjeld Schmiegelow, MD4, Gunnar Cario, MD27*, Arend von Stackelberg, MD29*, Peter Horvath9,30*, Beat Bornhauser, PhD1* and Jean-Pierre Bourquin, MD, PhD31

1Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland
2Department of Hematology and Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany
3Department of Pediatrics, Universitätsklinikum Schleswig-Holstein, Kiel, Germany
4Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
5Pediatric Hematopoietic Stem Cell Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
6Department of Medicine and Surgery, Milano-Bicocca University, Milano, Italy
7Department of Pediatric Hematology and Oncology, University of Padova, Padua, Italy
8Schneider Children's Medical Center, Petah Tikva, Israel
9Single-cell Technologies, Szeged, Hungary
10Finnish Institute of Molecular Medicine, Helsinki, Finland
11CHUV University Hospital, Lausanne, VD, Switzerland
12Department of Paediatrics Haematology and Oncology, University Hospital Motol, Prague, Czech Republic
13Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria
14Aarhus University Hospital, Aarhus, Denmark
15Kantonsspital Aarau, Aarau, Switzerland
16Hôpital Universitaire de Genève, Switzerland, Geneve, Switzerland
17Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
18Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Aviv, Israel
19Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
20Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium
21Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
22Karolinska University Hospital, Stockholm, Sweden
23Universitäts-Kinderspital beider Basel, Basel, Switzerland
24Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
25Hôpital Robert Debré, Paris, France
26Department of Pediatrics, Catholic University of the Sacred Heart, Rome, Italy
27Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany
28Department of Pediatric Oncology, Hematology, and Immunology and Hopp-Children’s Tumor Center, University of Heidelberg and DKFZ, Heidelberg, Germany
29Department of Pediatric Oncology and Hematology, Charité Universitaetsmedizin Berlin, Berlin, Germany
30Biological Research Centre, Szeged, Hungary
31Department of Oncology and Children’s Research Center, University Children's Hospital Zurich, Zurich, Switzerland

Stuart Adams1*, Jeremy Hancock2*, Joe Kaplinsky3*, Alona Sosinsky3*, Gary Wright1*, Soragia Athina Gkazi1*, Susanne Kricke1*, Rebecca Thomas1*, Natalie Kent1*, Angus Hodder, MBBS4* and Jack Bartram4,5*

1Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
2Southmead Hospital, Bristol Genetics Laboratory, Bristol, United Kingdom
3Genomics England, London, United Kingdom
4Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
5North Thames Genomic Laboratory Hub, Londom, United Kingdom

Jesús Gutiérrez-Abril1*, Gunes Gundem2*, Elise Fiala3*, Konstantinos Liosis3*, Noushin Farnoud, PhD3*, Daniel Leongamornlert, PhD4*, Anu Amallraja3*, Juan E. Arango Ossa2*, Dylan Domenico3*, Max F. Levine5*, Juan Santiago Medina Martinez5*, Michael F. Walsh, MD3*, Sylwia Jasinski, MD6*, Andrew L. Kung, MD, PhD3, Neerav N. Shukla7, William L. Carroll, MD8 and Elli Papaemmanuil3

1Department of Epidemiology & Biostatistics, Universidad De Oviedo, Oviedo, Spain
2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
4Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, United Kingdom
5Isabl Inc., New York, NY
6Department of Pediatrics, NYU Long Island School of Medicine, Mineola, NY
7Memorial Sloan Kettering Cancer Center, New York, NY
8Perlmutter Cancer Center, Department of Pediatrics and Pathology, NYU Grossman School of Medicine, New York, NY

Adrian Mosquera Orgueira, MD, PhD1*, Olga Krali2*, Andres Peleteiro Raindo3*, Jose Angel Diaz Arias4*, Marta Sonia Gonzalez Perez5*, Manuel Perez Encinas6*, Manuel Fernandez Sanmartin7*, Natalia Alonso Vence8*, Daniel Sinnett, PhD9*, Mats Heyman10, Gudmar Lönnerholm11*, Ulrika Norén-Nyström, MD, PhD12*, Kjeld Schmiegelow13 and Jessica Nordlund2*

1University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
2Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
3University Hospital of Santiago De Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, ESP
4University Hospital of Santiago de Compostela, Department of Hematology, IDIS, A Coruña, Spain
5University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
6University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO, ESP
7University Hospital of Santiago de Compostela, Department of Pediatrics, IDIS, Santiago de Compostela, Spain
8University Hospital of Santiago de Compostela, Department of Hematology, IDIS, Santiago de Compostela, Spain
9Hopital Ste.-Justine Centre de Cancerologie Charles Brunea, Montreal, QC, CAN
10Childhood Cancer Research Unit, Karolinska Institute, Stockholm, Sweden
11Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
12Department of Clinical Sciences, Pediatrics, Umeå University Hospital, Umeå, Sweden
13Copenhagen University, Copenhagen, DNK

Sonja Bendig1,2*, Sandra Bufe, PhD3*, Birgit Fricke3*, Constantin Proske3*, Nikos Darzentas, PhD3*, Britta Kehden3*, Guranda Chitadze2,3*, Claudia D Baldus, MD2,4*, Michaela Kotrova, MD, PhD3*, Nicola Goekbuget, MD5 and Monika Brüggemann, MD2,3*

1University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
2Clinical Research Unit CATCH ALL (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
3Medical Department II, Hematology/Oncology, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
4Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
5Goethe University Hospital, Frankfurt, Germany

Jim Zhongning Chen, MD1, Alan Baltz, MD2*, Tyler Fugere, MD3, Emily Noel Sanders, MD4*, Fnu Amisha, MD5, Cesar Giancarlo Gentille Sanchez, MD3* and Maria Alejandra Pereda, MD6*

1Department of Hematology Oncology, UAMS, AR, AR
2UAMS, Little Rock, AR
3University of Arkansas for Medical Sciences, Little Rock, AR
4Arkansas Children's Hospital, Little Rock, AR
5H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL
6Center for Cancer and Blood Disorders, Children’s Hospital, University of Colorado, Aurora, CO

Abhijit Chakraborty, PhD1*, Laura Hinojosa2*, Vivek Chandra1*, Benjamin Schmiedel, PhD3*, Monalisa Mondal4*, Nirmalya Dasgupta, PhD1*, Pandurangan Vijayanand, MD, PhD5*, Preethi Ganesan, MD, PhD3* and Ferhat Ay4*

1La Jolla Institute for Immunology, La Jolla, CA
2La Jolla Institute For Immunology, La Jolla
3La Jolla Institute for Immunology, La Jolla
4LA JOLLA INSTITUTE FOR IMMUNOLOGY, La Jolla, CA
5La Jolla Institute For Immunology, La Jolla, CA

*signifies non-member of ASH